Skip to content
CovaSyn
Log in
Intro call

Discovery and biologics · Biologics: developability and sequence design

Our candidates fail late on viscosity, aggregation or immunogenicity.

Spot developability risks in your candidates early, before they become expensive.

Who needs this in your company

Roles

Industries

What we can do

We assess the developability of antibodies and other biologics from the sequence, predict viscosity at high concentration, immunogenicity and deamidation and support the design of ADCs, mRNA, siRNA, oligos and peptides.

What you get

  • Developability report for your candidate list
Do it yourself: How developable is my antibody?

Evaluated for you or done yourself

The same calculations, different ways to you. Which one fits, we work out in the intro call.

  • CovaSyn in your AI (MCP)

    The same calculations directly in Claude, ChatGPT or your own AI.

    Learn more

  • Evaluation report

    You send the data, we deliver the reviewed report.

    From EUR 1,490 net, typically 5 working days after complete data

    Learn more

  • Sketcher in the browser

    Draw a molecule and run the evaluation yourself in the browser.

    Free, Pro EUR 250, Max EUR 750 per user and month, net

    Learn more

  • Pilot project

    One question on your data, with a success criterion agreed in writing beforehand.

    From EUR 1,490 net, fully creditable

    Learn more

  • Co-development and custom models

    Models and workflows on your data, developed together in milestones.

    Price on request

    Learn more

  • Joint funded project

    A joint project with public funding, we take on the computational part.

    Public funding plus own contribution

    Learn more

Limits of the result

  • Sequence-based predictions do not replace formulation experiments.

More from this area

Next step

Which case is on your desk right now?

30 minutes on Microsoft Teams with the CovaSyn team. If it is not a fit, we will say so.